Analysts at StockNews.com initiated coverage on shares of Arch Biopartners (NYSE:ARCH – Get Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.
Arch Biopartners Stock Performance
Shares of NYSE:ARCH opened at $134.83 on Friday. Arch Biopartners has a 52-week low of $116.44 and a 52-week high of $180.65.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Arch Biopartners stock. Total Clarity Wealth Management Inc. acquired a new position in Arch Biopartners Inc. (NYSE:ARCH – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 329 shares of the company’s stock, valued at approximately $47,000.
Featured Stories
- Five stocks we like better than Arch Biopartners
- 3 Monster Growth Stocks to Buy Now
- The Most Inspiring Small Businesses of 2025 [Survey]
- Canadian Penny Stocks: Can They Make You Rich?
- Microsoft Crushes Earnings, What’s Next for MSFT Stock?
- How Can Investors Benefit From After-Hours Trading
- McDonald’s Insiders Sell Shares! Investors Should Do the Opposite
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
